Introduction:
The cell and gene therapy market in China is experiencing rapid growth and is expected to continue to expand in the coming years. With advancements in technology and research, China has become a key player in the global cell and gene therapy industry. According to industry reports, the market size for cell and gene therapy in China is projected to reach $X billion by 2026, showcasing the country’s significant contribution to the sector.
Top 10 Global Cell and Gene Therapy Companies in China 2026:
1. BeiGene
BeiGene is a leading biotechnology company in China specializing in developing innovative therapies for cancer. The company has shown impressive growth in recent years, with a market share of X% in the cell and gene therapy sector.
2. Legend Biotech
Legend Biotech is a pioneer in the field of cell therapy and has gained recognition for its CAR-T therapy products. The company has seen a significant increase in production volume, with exports to various countries around the world.
3. Cellular Biomedicine Group (CBMG)
CBMG is a key player in the cell therapy market in China, with a strong focus on developing personalized therapies for cancer patients. The company has reported a trade value of $X million in 2026, showcasing its growing presence in the global market.
4. Shanghai Genechem Co., Ltd.
Shanghai Genechem is a prominent player in the gene therapy sector, with a wide range of products aimed at treating genetic disorders. The company has reported a production volume of X units in 2026, demonstrating its commitment to innovation and quality.
5. Gracell Biotechnologies
Gracell Biotechnologies is known for its cutting-edge research in cell therapy and has gained recognition for its novel approaches to treating diseases. The company has reported a market share of X% in China, indicating its strong position in the industry.
6. JW Therapeutics
JW Therapeutics is a leading biopharmaceutical company in China specializing in gene therapy products. The company has reported an impressive growth rate of X% in 2026, highlighting its potential for further expansion in the global market.
7. Zai Lab
Zai Lab is a fast-growing biotechnology company in China focused on developing innovative therapies for various diseases. The company has reported a trade value of $X million in 2026, showcasing its success in the international market.
8. GenScript Biotech Corporation
GenScript Biotech is a major player in the gene therapy sector, with a diverse portfolio of products and services. The company has reported a production volume of X units in 2026, highlighting its strong presence in the global market.
9. I-Mab Biopharma
I-Mab Biopharma is known for its research in immunotherapy and has gained recognition for its innovative approach to treating cancer. The company has reported a market share of X% in China, indicating its growing influence in the industry.
10. CARsgen Therapeutics
CARsgen Therapeutics is a leading biotechnology company in China specializing in CAR-T therapy products. The company has shown significant growth in recent years, with exports to multiple countries around the world.
Insights:
The cell and gene therapy market in China is poised for continued growth in the coming years, driven by increasing investments in research and development. With advancements in technology and a growing demand for personalized therapies, Chinese companies are well-positioned to lead the global market. According to industry forecasts, the market size for cell and gene therapy in China is projected to double by 2026, reaching $X billion. This growth presents significant opportunities for companies in China to expand their presence in the global market and drive innovation in the field.
Related Analysis: View Previous Industry Report
